Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent-Reference-Cited by-同舟云学术

Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent

Published:2015-10-19 Issue:1 Volume:7 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Tang Yun-Zhao,Wang Gang,Jiang Zhen-Huan,Yan Tian-Tian,Chen Yi-Jun,Yang Min,Meng Ling-Ling,Zhu Yan-Juan,Li Chen-Guang,Li Zhu,Yu Ping,Ni Chang-Lin

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13098-015-0087-3

Reference33 articles.

1. World Health Organization. Diabetes key facts. http://www.who.int/mediacentre/factsheets/fs312/en/ .

2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–245.

3. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.

4. Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;372(23):2197–206.

5. Leslie RD. United Kingdom prospective diabetes study (UKPDS): what now or so what? Diabetes/Metab Res Rev. 1999;15(1):65–71.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning assessment of vildagliptin and linagliptin effectiveness in type 2 diabetes: Predictors of glycemic control;PLOS ONE;2024-08-26

2. Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin;Cureus;2024-04-12

3. A systematic review on the clinical pharmacokinetics of vildagliptin in healthy and disease populations;Expert Opinion on Drug Metabolism & Toxicology;2023-11-26

4. Role of DPP4 and DPP4i in Glucose Homeostasis and Cardiorenal Syndrome;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-02

5. The Emerging Role of the Gut Microbiome in Hematopoietic Stem Cell Transplantation;Reference Module in Biomedical Sciences;2023